Literature DB >> 24488810

CD34+ stromal cells/fibroblasts/fibrocytes/telocytes as a tissue reserve and a principal source of mesenchymal cells. Location, morphology, function and role in pathology.

L Díaz-Flores2, R Gutiérrez2, M P García3, F J Sáez4, L Díaz-Flores2, F Valladares5, J F Madrid6.   

Abstract

We review the morphofunctional characteristics of CD34+ stromal fibroblastic/fibrocytic cells (CD34+ SFCs) and report our observations. We consider the following aspects of CD34+ SFCs: A) The confusing terms applied to this cell type, often combining the prefix CD34 with numerous names, including fibroblasts, fibrocytes, dendrocytes, keratocytes, telocytes and stromal, dendritic, adventitial, supraadventitial, perivascular, paravascular and delimiting cells; B) Changes in their immunophenotype, e.g., loss of CD34 expression and gain of other markers, such as those defining mesenchymal and derivate cells (myofibroblasts, osteoblasts, chondroblasts, adipocytes); C) Morphology (elongated or triangular cell body and thin, moniliform, bipolar or multipolar cytoplasmic processes), immunohistochemistry (co-expression of and changes in molecular expression) and structure (characteristics of nucleus and cytoplasmic organelles, and points of contact and junctions in quiescent and activated stages by light and electron microscopy); D) Location and distribution in the vessels (adventitia or external layer), in the tissues (connective, adipose, blood, muscle and nervous) and in the organs and systems (skin, oral cavity and oropharynx, respiratory, digestive, urinary, male, female, endocrine and lymphoid systems, serosal and synovial membranes, heart, eye and meninges); E) Origin from the mesoderm and cranial neural crest in the embryo, and from stem cells (themselves or other cells) and/or peripheral blood pluripotent stem cells (circulating progenitor cells) in post-natal life; F) Functions, such as synthesis of different molecules, progenitor of mesenchymal cells, immunomodulation, parenchymal regulation (growth, maturation and differentiation of adjacent cells), induction of angiogenesis, scaffolding support of other cells and phagocytic properties. Since CD34+ SFCs are the main reservoir of tissue mesenchymal cells (great mesenchymal potential, probably higher than that proposed for pericytes and other stromal cells), we dedicate a broad section to explain their in vivo behaviour during proliferation and differentiation in different physiologic and pathologic conditions, in addition to their characteristics in the human tissues of origin (adult stem cell niches); G) Involvement in pathological processes, e.g., repair (regeneration and repair through granulation tissue), fibrosis, tumour stroma formation and possible CD34+ SFC-derived tumours (e.g., solitary fibrous tumour, dermatofibrosarcoma protuberans, giant cell fibroblastoma, nuchal-type fibroma, mammary and extramammary myofibroblastoma, spindle and pleomorphic cell lipoma, and elastofibroma) and H) Clinical and therapeutic implications.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24488810     DOI: 10.14670/HH-29.831

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  61 in total

1.  Vascular alterations after photodynamic therapy mediated by 5-aminolevulinic acid in oral leukoplakia.

Authors:  Flávia Cristina Perillo Rosin; Ana Rita Ribeiro Barcessat; Giuliana Gadoni Giovanni Borges; Luciana Gonçalves Valente Ferreira; Luciana Corrêa
Journal:  Lasers Med Sci       Date:  2016-12-21       Impact factor: 3.161

Review 2.  Intussusceptive angiogenesis and its counterpart intussusceptive lymphangiogenesis.

Authors:  L Díaz-Flores; R Gutiérrez; S Gayoso; M P García; M González-Gómez; L Díaz-Flores; R Sánchez; J L Carrasco; J F Madrid
Journal:  Histol Histopathol       Date:  2020-04-24       Impact factor: 2.303

3.  CD26 Identifies a Subpopulation of Fibroblasts that Produce the Majority of Collagen during Wound Healing in Human Skin.

Authors:  Christal A Worthen; Yilei Cui; Jeffrey S Orringer; Timothy M Johnson; John J Voorhees; Gary J Fisher
Journal:  J Invest Dermatol       Date:  2020-05-11       Impact factor: 8.551

4.  Marker Expression of Interstitial Cells in Human Skeletal Muscle: An Immunohistochemical Study.

Authors:  Eva K Hejbøl; Mohammad A Hajjaj; Ole Nielsen; Henrik D Schrøder
Journal:  J Histochem Cytochem       Date:  2019-08-14       Impact factor: 2.479

5.  Altered Dermal Fibroblasts in Systemic Sclerosis Display Podoplanin and CD90.

Authors:  Banafsheh Nazari; Lisa M Rice; Giuseppina Stifano; Alexander M S Barron; Yu Mei Wang; Tess Korndorf; Jungeun Lee; Jag Bhawan; Robert Lafyatis; Jeffrey L Browning
Journal:  Am J Pathol       Date:  2016-08-23       Impact factor: 4.307

6.  Mesenchymal Stem Cell-Like Properties of Orbital Fibroblasts in Graves' Orbitopathy.

Authors:  Katarzyna Kozdon; Caroline Fitchett; Geoffrey E Rose; Daniel G Ezra; Maryse Bailly
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-09       Impact factor: 4.799

7.  Fibrocyte migration, differentiation and apoptosis during the corneal wound healing response to injury.

Authors:  Luciana Lassance; Gustavo K Marino; Carla S Medeiros; Shanmugapriya Thangavadivel; Steven E Wilson
Journal:  Exp Eye Res       Date:  2018-02-24       Impact factor: 3.467

8.  Nuchal-type fibroma of the shoulder: A case report and review of the literature.

Authors:  Yubao Gong; Xingyu Zhao; D I Wu; Jianguo Liu
Journal:  Oncol Lett       Date:  2016-05-05       Impact factor: 2.967

Review 9.  Telocytes: An Emerging Component of Stem Cell Niche Microenvironment.

Authors:  Irene Rosa; Mirca Marini; Mirko Manetti
Journal:  J Histochem Cytochem       Date:  2021-06-24       Impact factor: 2.479

10.  Single-Cell RNA Sequencing of Lymph Node Stromal Cells Reveals Niche-Associated Heterogeneity.

Authors:  Lauren B Rodda; Erick Lu; Mariko L Bennett; Caroline L Sokol; Xiaoming Wang; Sanjiv A Luther; Ben A Barres; Andrew D Luster; Chun Jimmie Ye; Jason G Cyster
Journal:  Immunity       Date:  2018-05-08       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.